SEOM guideline in ovarian cancer 2014

Ovarian cancer is the leading cause of death due to gynecological cancer and the 5th cause of death for cancer in women in Europe. Optimal management of patients with ovarian cancer needs the participation of a well-trained multidisciplinary team. In the last few years, we have observed a significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Martín, A., Bover, I., Del Campo, J. M., Redondo, A., Vidal, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2014
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239783/
https://www.ncbi.nlm.nih.gov/pubmed/25351169
http://dx.doi.org/10.1007/s12094-014-1229-z
_version_ 1782345640407203840
author Gonzalez-Martín, A.
Bover, I.
Del Campo, J. M.
Redondo, A.
Vidal, L.
author_facet Gonzalez-Martín, A.
Bover, I.
Del Campo, J. M.
Redondo, A.
Vidal, L.
author_sort Gonzalez-Martín, A.
collection PubMed
description Ovarian cancer is the leading cause of death due to gynecological cancer and the 5th cause of death for cancer in women in Europe. Optimal management of patients with ovarian cancer needs the participation of a well-trained multidisciplinary team. In the last few years, we have observed a significant improvement in the knowledge of the molecular biology of the different histotypes of ovarian cancer that will probably change our standard of care in the forthcoming years. In this Guideline, we summarize the most current evidence for the medical management of ovarian cancer.
format Online
Article
Text
id pubmed-4239783
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-42397832014-11-25 SEOM guideline in ovarian cancer 2014 Gonzalez-Martín, A. Bover, I. Del Campo, J. M. Redondo, A. Vidal, L. Clin Transl Oncol Clinical Guides in Oncology Ovarian cancer is the leading cause of death due to gynecological cancer and the 5th cause of death for cancer in women in Europe. Optimal management of patients with ovarian cancer needs the participation of a well-trained multidisciplinary team. In the last few years, we have observed a significant improvement in the knowledge of the molecular biology of the different histotypes of ovarian cancer that will probably change our standard of care in the forthcoming years. In this Guideline, we summarize the most current evidence for the medical management of ovarian cancer. Springer Milan 2014-10-29 2014 /pmc/articles/PMC4239783/ /pubmed/25351169 http://dx.doi.org/10.1007/s12094-014-1229-z Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Clinical Guides in Oncology
Gonzalez-Martín, A.
Bover, I.
Del Campo, J. M.
Redondo, A.
Vidal, L.
SEOM guideline in ovarian cancer 2014
title SEOM guideline in ovarian cancer 2014
title_full SEOM guideline in ovarian cancer 2014
title_fullStr SEOM guideline in ovarian cancer 2014
title_full_unstemmed SEOM guideline in ovarian cancer 2014
title_short SEOM guideline in ovarian cancer 2014
title_sort seom guideline in ovarian cancer 2014
topic Clinical Guides in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239783/
https://www.ncbi.nlm.nih.gov/pubmed/25351169
http://dx.doi.org/10.1007/s12094-014-1229-z
work_keys_str_mv AT gonzalezmartina seomguidelineinovariancancer2014
AT boveri seomguidelineinovariancancer2014
AT delcampojm seomguidelineinovariancancer2014
AT redondoa seomguidelineinovariancancer2014
AT vidall seomguidelineinovariancancer2014

Ejemplares similares